Pharmaceutical Technology on MSN
Solstice Oncology secures $225m to drive porustobart’s development for cancer
The funding round was led by RA Capital Management, with participation from Canaan Partners, Forbion and other investors.
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today ...
Today, shares of Harbour BioMed (the "Company"; HKEX: 02142.HK) were officially included in the eligible shares list of the Stock Connect. Effective immediately, qualified investors in mainland China ...
Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed, commented: "In the first half of 2026, Harbour BioMed continued to advance our Phase 3.0 strategy, with meaningful progress across all ...
The 601 Congress St. Property In Boston's Seaport. BioMed Realty Trust is acquiring the former John Hancock Life Insurance Co. headquarters in the Seaport, its first foray into the neighborhood ...
- BioMed Realty Continues to Support California’s Life Science Industry Growth with $2.6 Billion Capital Commitments in Last Four Years SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“BioMed”), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results